Evidence map›Paper›PMID 32179576›Full record

ArticleAnnals of the rheumatic diseases2020

Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic

Riitta Tuompo, Tinja Lääveri, Timo Hannu, Sari H Pakkanen, Juha Kirveskari, Marjatta Leirisalo-Repo, Anu Kantele

Open access · hybridAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. [Update: enterogenic spondylarthritis].Zeitschrift fur Rheumatologie · 2021
    Article
  7. The Changing Face of the FamilyClinical microbiology reviews · 2021
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Riitta TuompoInflammation Center, Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland riitta.tuompo@hus.fi.ORCID 0000-0003-2559-5904
Tinja LääveriInflammation Center, Department of Infectious diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Timo HannuDepartment of Public Health, University of Helsinki, Helsinki, Finland.
Sari H PakkanenHuman Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Juha KirveskariDepartment of Bacteriology, Helsinki University Hospital Laboratory, Helsinki, Finland.
Marjatta Leirisalo-RepoInflammation Center, Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Anu KanteleInflammation Center, Department of Infectious diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesUsing a prospective research design, we evaluated the association between acquisition of diarrhoeagenic

methodsA total of 526 study participants were asked to provide pretravel and post-travel stool samples and fill in questionnaires (pretravel, post-travel and 3-week follow-up). A multiplex quantitative PCR assay was deployed to detect five DEC comprising enteroaggregative

resultsFrom among the total of 224 volunteers who returned all questionnaires and stool specimens, 38 (17.0%) reported MSK symptoms. Multivariate analysis revealed that acquisition of DEC was associated with MSK symptoms (OR 3.9; 95% CI 1.2 to 13.3). Of the 151 with only-DEC, four (2.6%) had ReA, two (1.3%) reactive tendinitis and three (2.0%) reactive arthralgia. ReA was mostly mild, and all patients with ReA were negative for human leucocyte antigen B27. Antibiotic treatment of travellers' diarrhoea did not prevent development of MSK symptoms.

conclusionA total of 17% of volunteers reported post-travel MSK symptoms. DEC acquisition was associated with an increased risk of developing them, yet the ReA incidence remained low and the clinical picture mild. Antibiotic treatment did not protect against development of MSK symptoms.

Indexed as

Travel-Related IllnessAcademic Medical CentersAnti-Bacterial AgentsArthritis, ReactiveCohort StudiesDiarrheaEscherichia coliEscherichia coli InfectionsFemaleFinlandHumansIncidenceLogistic ModelsMaleMiddle AgedMultiplex Polymerase Chain ReactionAnti-Bacterial AgentsPHB2 protein, humanProhibitinsarthritisinfectionsreactive arthritisspondyloarthritis

Identifiers

PMID32179576
PMCPMC7213310
OpenAlexW3011718808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.